Based on previously published observations regarding the prohomologous to the newly described human A1, 14 or 15 tective effects of interleukin-1 (IL-1) and tumor necrosis factor a Bcl-2-related gene. Lake City, UT, USA) and used at 1.2% to induce differen-
tiation. Dainippon interleukin-1 alpha was obtained from Dr A Fallavollita, NCI, NIH, Bethesda, MD, USA; TNF␣ was a gift from Knoll Pharmaceutical Company (Whippany, NJ, Introduction USA), and granulocyte colony-stimulating factor (G-CSF) was a gift from Amgen Biologicals (Thousand Oaks, CA, USA). We and others have reported previously on the protective effects of interleukin-1 (IL-1) and/or tumor necrosis factor alpha (TNF␣) against different chemotherapeutic agents, gamma radiation, and ultraviolet radiation. [1] [2] [3] [4] [5] [6] [7] [8] [9] This protective Cell culture effect was described mainly for human and mouse hematopoietic progenitors and occasionally tumor cells. The mechThe A549 lung carcinoma cell line as well as the leukemic anism of protection has been attributed to the induction of cell lines HL-60, KG-1, K562, U-937, and THP-1 were Mn superoxide dismutase (MnSOD) for radioprotection and obtained from the American Tissue Culture Collection (ATCC, aldehyde dehydrogenase class-1 (ALDH-1) for protection Rockville, MD, USA). Growth factor dependent TF-1 leukemic against 4-hydroperoxycyclophosphamide (4-HC), an active cell line was obtained from Dr A Miller, Tulane University, derivative of cyclophosphamide. Both enzymes were shown New Orleans, LA, USA. All cell lines were grown in RPMI to be induced by IL-1 and/or TNF␣. 10, 11 The overexpression 1640 medium supplemented with 10% fetal calf serum (FCS) of MnSOD and ALDH-1 promotes resistance to radiation and except for HL-60 and KG-1 cells which were grown in IMDM 4-HC, respectively. 12, 13 medium supplemented with 20% FCS. Epstein-Barr virus Due to the wide in vitro protective effects of IL-1 and TNF␣, (EBV)-positive B cell line (AL-M3) used in this study was estaband the fact that these cytokines are proinflammatory and lished in our laboratory from a patient with acute promyelostress-related, we hypothesized that the induction of MnSOD cytic leukemia. All cells were used in their exponential and ALDH-1 can be the end product of a 'stress'-like response growth phase. induced by these cytokines and mediated by other early Under exemption status approved by the Institutional response cellular gene(s). In order to study that hypothesis, we Review Board, post-Ficoll-Hypaque bone marrow (BM) chose A549 lung carcinoma cell line in which MnSOD was mononuclear cells (MNC) were obtained from discarded, preinduced by IL-1 (J Zucali, personal communication). A549 viously stored samples from normal bone marrow donors or cells were incubated with IL-1 for 1, 2, and 6 h and RNA was G-CSF-mobilized peripheral blood progenitors obtained by extracted at each interval. One of several cDNA fragments leukapheresis (normally у90% mononuclear) from patients up-regulated by IL-1 and identified using mRNA differential undergoing autologous stem cell transplantation. Several BM display (DD) was cloned, sequenced, and found to be samples from different normal donors were used. These samples were frozen in liquid nitrogen until used in this study. Similarly, freshly isolated leukemic cells were obtained from Incubations with IL-1, TNF␣, and differentiating a nested primer upstream to the first strand cDNA primer (5Ј-TCTGGAAGGTCAAGTTAC-3Ј). This PCR amplification of the factors cDNA was performed using a thermal cycler at 94°C for 5 min, 80°C for 1 min, 55°C for 2 min, and 72°C for 2 min All cells were incubated with 50 ng/ml IL-1 or 25 ng/ml TNF␣ for 6 h, in the appropriate culture medium. In addition, some for one cycle, then 94°C/2min, 55°C/2 min, 72°C/2 min for 40 cycles, followed by a final cycle at 72°C for 10 min. BM samples were incubated with the combination of 10 ng/ml IL-1 and 5 ng/ml TNF␣, because such a combination was
The PCR product was isolated from a 1.5% nusieve agarose gel and ligated into pT7-blue T-vector. Automated sequencing shown to have synergistic protective effects for hematopoietic progenitors against 4-HC. 1 Similar incubation of BM-MNCs was performed by the ICBR DNA sequencing core facility at the University of Florida. Sequencing was accomplished by with 100 ng/ml of G-CSF was also performed. The respective BM samples were also incubated with culture medium only employing the Taz DyeDeoxy Termination and the DyePrimer Cycle Sequencing protocols developed by Applied Biosystems and used as controls. For induction of differentiation, the following factors were added to the cell cultures: DMSO 1.2%
(a division of Perkin-Elmer, Foster City, CA, USA) using fluorescent-labeled dideoxynucleotides and primers, respectively. for 3-6 days, ATRA 10 −6 M for 3 days, PMA 10 −7 M for 1 day, hemin 0.1 mM for 3 days. [16] [17] [18] [19] [20] Differentiation was determined The labeled extension products were analyzed on an Applied Biosystems Model 373A DNA Sequencer. Databases were by direct observation of the cell cultures as well as cell morphology observed on cytocentrifuge slides fixed and stained searched using the BLAST algorithm. 22 by Wright's stain.
Northern analysis mRNA differential display Total RNA was extracted using the method of Chomczynski and Sacchi 24 from leukemic cells, normal hematopoietic proThe reactions for the mRNA differential display were performed as described previously, 21 at the Interdisciplinary Center genitors and A549 lung carcinoma cell lines after incubation with IL-1, TNF␣ or differentiating factors as indicated. for Biotechnology Research (ICBR) core facility, University of Florida. In brief, total RNA obtained from A549 lung cancer Total RNA (usually 20 g per lane, unless indicated otherwise) was separated on 1.2% agarose formaldehyde gels, cells incubated with 50 ng/ml IL-1 for 0, 1, 2, and 6 h was reverse transcribed using the 3Ј anchored primers (5Ј-blotted onto Hybond-N nylon filters (Amersham, Cleveland, OH, USA), and hybridized overnight at 42°C with random-AAGCTTTTTTTTTTTG-3Ј; 5Ј-AAGCTTTTTTTTTTTA-3Ј; 5Ј-AAGCTTTTTTTTTTTC-3Ј) followed by a PCR reaction using primer ( 32 P)dCTP-labelled probes. After 16-20 h hybridization, the blots were washed with 0.2 × SSC and 0.1% SDS arbitrary 5Ј end primers (5Ј-AAGCTTGATTGCC-3Ј; 5Ј-AAGCTTCGACTGT-3Ј; 5Ј-AAGCTTTGGTCAG-3Ј; 5Ј-first in room temperature and then at 56°C. Blots were exposed to X-ray film with two intensifying screens at −80°C AAGCTTCTCAACG-3Ј) as well as the 3Ј anchored primers in order to amplify cDNA. This PCR amplification was perforand for various lengths of time, as indicated. Both the 136 bp mRNA differential display product and the 5Ј RACE product med using a thermal cycler at 94°C for 30 s, 40°C for 2 min, 72°C for 30 s, for 40 cycles, followed by a final cycle at 72°C consequently detected the 0.9 kb human A1 (Bfl-1) transcript. for 5 min. Amplified cDNAs which incorporated ␣( 33 P)-dATP were then separated on a 6% denaturing polyacrylamide sequencing gel which was blotted on Whatman 3 mm paper Results (Fisher Scientific, Norcross, GA, USA), dried without methanol-acidic acid fixing, and exposed to X-ray film. After Identification and cloning of human A1 (Bfl-1) developing the film, the autoradiogram and dry gel were oriented with needle punches and the cDNA bands of interest In order to identify cellular genes that are influenced by IL-1, we have performed mRNA DD using RNA extracted from were located and excised. Recovered cDNA fragments were reamplified by PCR using similar conditions but without A549 cells that were incubated with 50 ng/ml of IL-1 at 0, 1, 2, and 6 h. Several messages were found to be either up-or ␣( 33 P)dATP, and cloned into the pT7-blue T-vector (Novagen, Madison, WI, USA). The cDNA fragment of interest to this down-regulated upon exposure to IL-1. The cDNAs were excised from the gel, reamplified and cloned. One of these study, DD2, was 136 bp. This fragment was sequenced using sequenase dideoxyterminator kit (USB Biochemicals, ClevecDNAs, a 136 bp fragment (DD2) was up-regulated by IL-1 and is the subject of this report. The sequence of DD2 disland, OH, USA). Databases were searched using the BLAST algorithm. 22 played a 99% homology to a 219 bp gene signature (HUMGS-01288, accession number D20314) that was isolated from HL-60 cells after DMSO induced differentiation. 25 Using random primer labeled DD2, we have confirmed the up-regulation of Rapid amplification of cDNA ends (RACE) a 0.9 kb mRNA in A549 cells exposed to IL-1 for up to 6 h ( Figure 1 ). The full-length cDNA was synthesized as described by Frohman et al 23 using a 5ЈRACE kit (GIBCO-BRL, Gaithersburg, Using 5ЈRACE, a 763 bp cDNA was isolated, cloned and sequenced. Nucleic acid database search using this sequence MD, USA), following the manufacturer's instructions. Briefly, reverse transcription to synthesize the first strand cDNA revealed 100% homology to Bfl-1 15 and human A1, which are identical.
14 A 72% amino acid identity was reported to was performed using an internal antisense primer (5ЈGGGGACAAAATTTCCATAAC-3Ј) and total RNA extracted the murine A1 protein, 15 and therefore the name human A1 for this gene will be used throughout the manuscript. The from IL-1-treated A549 cells. This was followed by a deoxycytidine nucleotide tailing reaction using terminal deoxynucleoactual reading frame for human A1 is 528 bp encoding a protein 175 amino acids long with an apparent MW of tidyl transferase (TdT). Second strand cDNA was synthesized using an oligo-dG anchor primer (supplied with the kit) and 20 100 kDa.
Figure 1
Northern blot analysis of human A1 gene expression in A549 lung carcinoma cells. Northern blot was prepared by loading 20 g per lane of total RNA isolated from A549 cells treated with 50 ng/ml IL-1 for 0, 1, 2, and 6 h. The Northern blot was probed using random-primer 32 P-labeled DD2, a 136 bp fragment of A1. The autoradiograph exposure time was 7 days. Photograph of the corresponding ethidium bromide-stained gel is shown below the autoradiograph.
The effect of cytokines on human A1 expression in normal hematopoietic progenitors Because of our previous observations with regard to the protective effects of IL-1 or TNF␣ for hematopoietic progenitors mature cells, and supports the findings described below in which A1 is shown to be induced by differentiating factors.
hand, freshly isolated acute promyelocytic leukemia cells (M3-AML) were found to express A1 constitutively and
The effect of cytokines on human A1 expression in tumor cells responded to 6 h incubation with IL-7 by up-regulation of the A1 mRNA (Figure 5c ). A1 mRNA was induced in A549 lung carcinoma cells after In general, our results reveal that constitutive expression of human A1 in leukemic cells is low or undetectable. Clear up-6 h incubation with TNF␣; however, IL-1 was a more potent inducer (Figure 3b) . The difference in intensity of A1 regulation of A1 mRNA was induced by 6-h incubation with IL-1 and TNF␣ in HL-60 cells (Figure 3a) . Six-hour preincuexpression in A549 cells in Figure 1 vs Figure 3b is most likely due to the use of the 136 bp A1 probe in the first, while the bation with IL-1 or TNF␣ did not affect A1 expression either in TF-1 and THP-1 cells (Figure 3 ) nor in K562 and U-937 full-length A1 cDNA probe was used in the latter. cells (data not shown). On the other hand, A1 mRNA up-regulation was seen in KG-1 cells after 6 h incubation with TNF␣ ( Figure 4 ). Human A1 is expressed constitutively in one freshly
The effect of differentiating factors on human A1 expression cell survival was suggested.
14 A database search using the differential display fragment (DD2, 136 bp) revealed sequence homology to a 219 bp gene signature isolated from DMSO differentiated HL-60 cells. 25 differentiating factors as indicated in the Figures. HL-60 cells differentiated into granulocytes after a 3-day exposure to Therefore, we focused on studying the effect of differentiation on the expression of the human A1 gene in normal hemato-10 −6 M ATRA and after 3-6 day exposure to 1.2% DMSO with a corresponding up-regulation of A1 mRNA (Figure 6a ). Overpoietic vs leukemic cells. Our results indicate that A1 is expressed in normal BM cells, and more so in mature cells, night incubation of HL-60, TF-1, and U-937 with 10 −7 M PMA resulted in differentiation into macrophages that adhered to which is in agreement with previous reports about the expression of human A1, 15 as well as murine A1 26 in BM cells. the bottom of the plastic flask. This change was associated with up-regulation of A1 mRNA in all three cell lines Six hour incubation with IL-1 and/or TNF␣, but not G-CSF, resulted in an apparent up-regulation of A1 in normal (Figures 3 and 6b) . Exposure to PMA did not result in the upregulation of the A1 mRNA in KG-1 cells (Figure 6 ). On the BM/MNCs.
Figure 5
Northern blot analysis of human A1 gene expression in freshly isolated leukemia cells (B cell ALL and M3-AML) or newly established EBV-positive B cell line (AL-M3). Total RNA was isolated from the various cells after 6-h incubation with 50 ng/ml IL-1 or 25 ng/ml TNF␣, 3-day incubation with 10 −6 M ATRA or 1.2% DMSO, or culture medium only (control). Northern blots a and b were prepared by loading 20 g per lane of total RNA; however, Northern blot c was prepared by loading all the RNA isolated from 2.5 × 10 7 cells used for each experimental group. Also in Northern blot c, two controls were included, one of untreated cells incubated for 3 days in culture medium alone (lane 2), and another of untreated cells incubated for 6 h (lane 5). Northern blots a and b were probed using random-primer 32 P-labeled A1 cDNA while c was probed using similarly labeled DD2, a 136 bp fragment of A1. The autoradiograph exposure times were 24 h, 17 h, and 2 weeks, respectively. Photographs of the corresponding ethidium bromide-stained gels are shown below the autoradiographs. Note: There is no detectable ribosomal RNA by ethidium bromide stain in the last three lanes in Northern blot c; however, with 32 P-labeling, A1 mRNA was detected in the IL-1 treated group.
Our results also indicate that human A1 mRNA is expressed Bcl-2 homologue (BAX) required for the function of Bcl-2 and BCL-X L . 28 Karsan et al 14 reported the induction of human A1 constitutively at very low levels or not at all in leukemic cells. This expression is induced by IL-1 or TNF␣ in some leukemic in human endothelial cells by IL-1/TNF␣ as well as PMA. These investigators suggested a possible protective role for A1 cells (HL-60, KG-1, B cell ALL) as well as lung carcinoma A549 cells. Interleukin-6, interleukin-3, G-CSF and granuloin the endothelium during inflammatory response. Choi et al 15 reported an increase in A1 expression in stomach cancer vs cyte-macrophage colony-stimulating factor (GM-CSF) did not affect A1 expression in HL-60 cells (data not shown). Furthernormal stomach tissue. These investigators also reported abundant expression of A1 in BM cells and its presence in more, marked increases in human A1 expression were seen after induction of differentiation to granulocytes (HL-60, M3-Raji, HL-60 cells, fetal liver and in adult tissues such as lung, spleen and esophagus. AML) or macrophages (U-937, TF-1, HL-60, B-cell-ALL). The induction of erythroid differentiation in K562 and TF-1 by Considering the data available from our studies and that reported by others, the following conclusions can be made hemin did not result in an increase of human A1 mRNA. These results, and in view of the abundant A1 mRNA in perconcerning human A1: (1) it is expressed in normal tissue such as BM, lung, spleen, thymus, testis, esophagus, small intestine; ipheral blood progenitors, indicate that A1 is expressed predominantly in differentiated hematopoietic cells, specifically (2) it is induced by IL-1/TNF␣ in certain leukemic cells, normal BM cells, lung carcinoma and endothelial cells; and (3) it in the granulocyte/macrophage lineages.
Murine and human A1 were reported to be Bcl-2-related is up-regulated during the differentiation of leukemic cells to granulocytes and macrophages. In reviewing the published genes due to high amino acid homology. 14, 15, 26 It has been suggested that murine A1 prolongs cell survival and permits data on murine A1, some differences between human and murine A1 can be found. Murine A1 was reported to be myeloid differentiation, and possibly interacts with another our results, as well as those reported by others, 14, 15 show that human A1 is expressed in hematopoietic as well as non-hematopoietic tissues. In addition, we have shown that IL-1 and/or TNF␣ but not G-CSF induce human A1 expression in BM/MNCs, and that human A1 is expressed in B lymphoid leukemias. A likely explanation for contradictions in regard to G-CSF effect is most probably the length of incubation used, and its differentiation effect on the 32D cl3 cell line used.
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In spite of the differences, both murine and human A1 are expressed in BM cells, and specifically during myeloid but not erythroid differentiation.
The purpose of our study has been to identify genes involved in the protective effects of IL-1/TNF␣, and human A1 would appear to be a good candidate for that role. On the other hand, our previous observation that IL-1 and TNF␣ were selectively protective of normal hematopoietic progenitors rather than leukemic cells, 1, 2, 8 and our findings that human A1 is induced by IL-1/TNF␣ in normal progenitors as well as certain leukemic cells would suggest that human A1 is not the gene responsible for that phenomena. However, studies aimed at overexpression of human A1 in leukemic cells using retroviral vectors will allow us to address this issue in a direct manner. Furthermore, the induction of A1 in tumor cells (certain leukemias and lung carcinoma) by IL-1 or TNF␣ is of considerable interest. Depending on the biologic function of A1, the effects of these cytokines might be beneficial (if A1 is needed for differentiation), or detrimental (if A1 promotes survival) in these malignancies. Further studies are needed to address these issues.
Human A1 was reported to have extensive homology with Bcl-2 within BH1 and BH2 domains. 15 These two domains seem to be common to all Bcl-2-related genes including Mcl-1, a gene that was isolated from the ML-1 human myeloid leukemia cell line during phorbol ester-induced differentiation along the monocyte-macrophage pathway. 30 Expression of Mcl-1 was reported to increase early in myeloid cells programmed to differentiate and stop proliferating without dying. 30 Mcl-1 expression was also reported to correlate with survival of peripheral blood B lymphocytes. 31 It was proposed that Mcl-1 may provide limited protection against apoptosis compared with Bcl-2 and thus allow for physiologic cell death mechanisms to more easily override Mcl-1 protection so that terminally differentiated cells can expire in an appropriate fashion.
32, 33 Thus, based on the information discussed above, we propose a hypothesis that, among the Bcl-2-related genes, tiation. The finding that human A1 is expressed in malignant but not normal stomach cells 15 is in conflict with that notion but may reflect specific cell type activity. expressed exclusively in hematopoietic tissues, including BM, thymus and spleen, and induced in mouse BM cultures 29 and In summary, we have isolated and cloned the newly recognized human A1 gene based on mRNA differential display. macrophages 27 by GM-CSF. These same investigators also reported that G-CSF induced A1 during neutrophil differenWe have demonstrated that human A1 is expressed in normal human hematopoietic progenitors (especially more mature tiation of the murine myeloid cell line 32D cl3, that IL-1 and IL-6 did not affect A1 expression in the murine bone marrowperipheral blood progenitors), it is induced by IL-1 and TNF␣ in certain leukemic cell lines, normal BM cells, and lung carderived macrophages, and that A1 is expressed in myeloid and T lymphoid cell lines but not in cell lines of B lymphoid, cinoma cells and during granulocytic and macrophage differentiation of leukemic cells. Further studies are required to erythroid or non-hematopoietic lineages. On the other hand,
